CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy

Zuqiang LiuThe University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Department of Surgery, University of Pittsburgh,Pittsburgh, PA, USA

Roshni RavindranathanThe University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Department of Surgery, University of Pittsburgh,Pittsburgh, PA, USA

Jun LiThe University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Department of Surgery, University of Pittsburgh,Pittsburgh, PA, USA

Pawel KalinskiThe University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Department of Surgery, University of Pittsburgh,Pittsburgh, PA, USA;Immunology, University of Pittsburgh,Pittsburgh, PA, USA;Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Z. Sheng GuoThe University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Department of Surgery, University of Pittsburgh,Pittsburgh, PA, USACorrespondence[email protected]

David L. BartlettThe University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Department of Surgery, University of Pittsburgh,Pittsburgh, PA, USACorrespondence[email protected]

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy

KONI_S_1091554.pptx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy

KONI_S_1091554.pptx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date